A citation-based method for searching scientific literature

E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
Times Cited: 264



P H O'Donnell, N Wadhwa, K Danahey, B A Borden, S M Lee, J P Hall, C Klammer, S Hussain, M Siegler, M J Sorrentino, A M Davis, Y A Sacro, R Nanda, T S Polonsky, J L Koyner, D L Burnet, K Lipstreuer, D T Rubin, C Mulcahy, M E Strek, W Harper, A S Cifu, B Polite, L Patrick-Miller, K-Tj Yeo, Eky Leung, S L Volchenboum, R B Altman, O I Olopade, W M Stadler, D O Meltzer, M J Ratain. Clin Pharmacol Ther 2017
Times Cited: 44




List of shared articles



Times cited

Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests.
Alireza Tafazoli, Rama Krishna Guggilla, Zahra Kamel-Koleti, Wojciech Miltyk. Genes (Basel) 2021
1

Prospective CYP2C19 Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical Trial.
Sony Tuteja, Henry Glick, William Matthai, Irving Nachamkin, Ashwin Nathan, Karen Monono, Craig Carcuffe, Karen Maslowski, Gene Chang, Taisei Kobayashi,[...]. Circ Genom Precis Med 2020
13

Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
Brittany A Borden, Paige Galecki, Rebecca Wellmann, Keith Danahey, Sang Mee Lee, Linda Patrick-Miller, Matthew J Sorrentino, Rita Nanda, Jay L Koyner, Tamar S Polonsky,[...]. Pharmacogenet Genomics 2019
11

Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.
Brittany A Borden, Sang Mee Lee, Keith Danahey, Paige Galecki, Linda Patrick-Miller, Mark Siegler, Matthew J Sorrentino, Yasmin Sacro, Andrew M Davis, David T Rubin,[...]. Pharmacogenomics J 2019
5

Implementation and obstacles of pharmacogenetics in clinical practice: An international survey.
Elizabeth Abou Diwan, Ralph I Zeitoun, Lea Abou Haidar, Ingolf Cascorbi, Nathalie Khoueiry Zgheib. Br J Clin Pharmacol 2019
10


Pharmacogenetic Information in Clinical Guidelines: The European Perspective.
Jesse J Swen, Marga Nijenhuis, Mandy van Rhenen, Nienke J de Boer-Veger, Anne-Marie Buunk, Elisa J F Houwink, Hans Mulder, Gerard A Rongen, Ron H N van Schaik, Jan van der Weide,[...]. Clin Pharmacol Ther 2018
35

Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Rebecca Wellmann, Brittany A Borden, Keith Danahey, Rita Nanda, Blase N Polite, Walter M Stadler, Mark J Ratain, Peter H O'Donnell. Cancer 2018
5

Implementation of Pharmacogenomics in Everyday Clinical Settings.
Paul C D Bank, Jesse J Swen, Henk-Jan Guchelaar. Adv Pharmacol 2018
12

User considerations in assessing pharmacogenomic tests and their clinical support tools.
Gouri Mukerjee, Andrea Huston, Boyko Kabakchiev, Micheline Piquette-Miller, Ron van Schaik, Ruslan Dorfman. NPJ Genom Med 2018
25